Is anyone surprised that healthcare stocks (XLV), and biotechnology stocks, in particular (IBB), are among the top performers so far this year, after being the worst in 2016? Mean reversion is real, and there are fundamental reasons why this reversion trend may continue. And if you do your homework, there are individual stocks and active funds that we believe may be an even better way to play this fundamental trend. This article highlights a few...